Rabbit Multiclonal Brn-2 antibody. Suitable for ICC/IF, WB and reacts with Human, Mouse samples. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human POU3F2.
IgG
Rabbit
pH: 7.4
Preservative: 0.09% Sodium azide
Constituents: 99.91% PBS
Liquid
Multiclonal
ICC/IF | WB | |
---|---|---|
Human | Tested | Tested |
Mouse | Expected | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/100 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/200 | Notes - |
Species Mouse | Dilution info 1/200 | Notes - |
Transcription factor that plays a key role in neuronal differentiation (By similarity). Binds preferentially to the recognition sequence which consists of two distinct half-sites, ('GCAT') and ('TAAT'), separated by a non-conserved spacer region of 0, 2, or 3 nucleotides (By similarity). Acts as a transcriptional activator when binding cooperatively with SOX4, SOX11, or SOX12 to gene promoters (By similarity). The combination of three transcription factors, ASCL1, POU3F2/BRN2 and MYT1L, is sufficient to reprogram fibroblasts and other somatic cells into induced neuronal (iN) cells in vitro (By similarity). Acts downstream of ASCL1, accessing chromatin that has been opened by ASCL1, and promotes transcription of neuronal genes (By similarity).
BRN2, OCT7, OTF7, BRN2, OCT7, POU3F2, OTF7, Brain-specific homeobox/POU domain protein 2, Nervous system-specific octamer-binding transcription factor N-Oct-3, Octamer-binding protein 7, Octamer-binding transcription factor 7, Brain-2, Brn-2, Oct-7, OTF-7
Rabbit Multiclonal Brn-2 antibody. Suitable for ICC/IF, WB and reacts with Human, Mouse samples. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human POU3F2.
IgG
Rabbit
pH: 7.4
Preservative: 0.09% Sodium azide
Constituents: 99.91% PBS
Liquid
Multiclonal
RP23040248
Blue Ice
1-2 weeks
+4°C
-20°C
Upon delivery aliquot
Avoid freeze / thaw cycle
Recombinant multiclonals are a mixture of recombinant antibodies co-expressed from a library of heavy and light chains.
Recombinant multiclonal antibodies offer the sensitivity of polyclonal antibodies by recognising multiple epitopes, along with consistency of a recombinant antibody.
This supplementary information is collated from multiple sources and compiled automatically.
Brn-2 also known as POU domain class 3 transcription factor 2 (POU3F2) is a transcription factor with a molecular weight of approximately 48 kDa. This protein plays a significant role in the development and function of the central nervous system. It is abundantly expressed in neuronal tissues and specific types of melanocytes. Brn-2 belongs to the POU domain family of proteins which are pivotal in regulating gene expression during development.
Brn-2 regulates the expression of genes critical for neural differentiation and development. It acts as a transcriptional activator that binds to specific DNA sequences. Brn-2 does not act alone; it often participates in regulatory complexes with other transcription factors. Through these interactions Brn-2 influences the fate of neural progenitor cells and is involved in the regulation of neural stem cell maintenance.
Brn-2 plays a role in the Wnt signaling pathway and the Notch signaling pathway. Both of these pathways are integral to cell fate determination during development. In the Wnt pathway Brn-2 may interact with proteins such as β-catenin which modulates the expression of genes involved in cell proliferation and differentiation. Additionally Brn-2's role in the Notch pathway can influence the activity of proteins like RBPJ impacting cell communication and developmental processes.
Brn-2 has been linked to melanoma and gliomas. In melanoma Brn-2 can interact with other proteins such as MITF influencing melanocyte development and contributing to cancer progression. In glioma Brn-2's aberrant expression might affect cellular pathways that lead to uncontrolled proliferation and tumor formation. Understanding these connections provides insights into potential therapeutic targets for these conditions.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Knockdown of Brn-2 was achieved by transfecting A-375 cells with Brn-2 specific siRNA. Western blot analysis was performed using modified whole cell extracts (1% SDS) from the A-375 knockdown cells (Lane 3), non-specific scrambled siRNA transfected cells (Lane 2) and untransfected cells (Lane 1). The blots were probed with ab308102 at 1/200 dilution and a Goat anti-Rabbit IgG (H+L) Secondary Antibody, HRP conjugate at 1/4,000 dilution. Loss of signal upon siRNA mediated knock down confirms that antibody is specific to POU3F2.
All lanes: Western blot - Anti-Brn-2 antibody [RP23040248] (ab308102) at 1/200 dilution
Lane 1: untransfected A375 cell lysate
Lane 2: non-specific siRNA transfected A375 cell lysate
Lane 3: Brn-2 specific siRNA transfected A375 cell lysate
All lanes: Goat anti-Rabbit IgG (H+L) Secondary Antibody, HRP conjugate at 1/4000 dilution
Observed band size: 54 kDa
Western blot analysis was performed on modified whole cell extracts (1%SDS) (30 µg lysate) of U-87 MG (Lane 1) and tissue extracts of Mouse pup brain (Lane 2) and Mouse brain (Lane 3). The blots were probed with ab308102 at 1/200 dilution and detected by chemiluminescence using a Goat anti-Rabbit IgG (H+L) Secondary Antibody, HRP conjugate at 1/4000 dilution. A ~54 kDa band corresponding to POU3F2 was observed across the cell lines and tissues tested.
All lanes: Western blot - Anti-Brn-2 antibody [RP23040248] (ab308102) at 1/200 dilution
Lane 1: U-87 MG cell lysate at 30 µg
Lane 2: Mouse pup brain tissue lysate at 30 µg
Lane 3: Mouse brain tissue lysate at 30 µg
All lanes: Goat anti-Rabbit IgG (H+L) Secondary Antibody, HRP conjugate at 1/4000 dilution
Observed band size: 54 kDa
For immunofluorescence analysis, Neural stem cells were fixed and permeabilized for detection of endogenous Brn-2 using ab308102 at 1/100 dilution and labeled with a Goat anti-Rabbit IgG (H+L) Secondary Antibody, Alexa Fluor® 488 conjugate at 1/2000 dilution.
Panel a) shows representative cells that were stained for detection and localization of Brn-2 protein (green)
Panel b) is stained for nuclei (blue) using DAPI
Panel c) represents cytoskeletal F-actin staining using Rhodamine Phalloidin at 1/300 dilution
Panel d) is a composite image of Panels a, b and c clearly demonstrating nuclear localization of Brn-2
Panel e) represents control cells with no primary antibody to assess background
The images were captured at 60X magnification
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com